Back to search

Article

Early Fc-effector antibody signatures impact COVID-19 disease trajectory

2026-02-19

Abstract excerpt

<h4>ABSTRACT</h4> Why do some individuals develop mild COVID-19 while others progress to severe disease remains a central challenge in SARS-CoV-2 immunology. In this study, we leveraged the BACO Cohort – a unique historical cohort of immunologically naïve, hospitalized COVID-19 patients from the first pandemic wave – to investigate early immune determinants of clinical disease trajectories. Integrating bulk RNA-s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3cc2bc61-c98b-5788-a778-efee4a85d8e9
DOI
10.64898/2026.02.18.26346542
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Early Fc-effector antibody signatures impact COVID-19 disease trajectoryDOI 10.64898/2026.02.18.26346542
Select a neighboring publication to make it the new centre.